Rehabilitation after reverse shoulder surgery
Official title: Immediate Accelerated Shoulder Rehabilitation Versus a Standard Protocol Following Reverse Total Shoulder Arthroplasty: A Randomized Controlled Trial
Run by HealthPartners Institute · NCT03804853 · Data updated 2026-11-12
This study tests whether starting active shoulder rehabilitation right after reverse shoulder surgery helps people over 55 recover better than traditional rehab methods.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 55 Years and up |
| Sex | All |
| Enrollment | 74 (estimated) |
| Sponsor | HealthPartners Institute Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Bloomington, Minnesota) |
| Status | Recruiting |
| Started | December 12, 2018 |
| Main results expected | December 31, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | June 26, 2026 |
| Trial ID | NCT03804853 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals over 55 years old who are scheduled for primary reverse total shoulder arthroplasty.
✕Probably not a fit
Patients with prior shoulder surgeries, active infections, or certain inflammatory conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of immediate active shoulder rehabilitation compared to traditional rehabilitation following reverse total shoulder arthroplasty (RTSA) in patients with shoulder osteoarthritis. Participants aged over 55 who are candidates for RTSA will be randomly assigned to either rehabilitation approach. The study aims to document clinical outcomes, complications, and cost-effectiveness over a one-year period. This research seeks to enhance recovery and functional outcomes for patients undergoing this surgical procedure.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery and functional outcomes for patients undergoing reverse total shoulder arthroplasty.
How similar studies have gone: While the concept of immediate rehabilitation post-surgery is not extensively studied, similar approaches in other orthopedic procedures have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \> 55 years of age. * Candidate for a primary reverse total shoulder arthroplasty. * Capable of completing self-administered questionnaires. * Be willing and able to return for all study-related follow-up procedures. * Able and willing to give informed consent. * Proficient in the English language. Exclusion Criteria: In-Clinic: * Patients planning on undergoing a Primary Reverse Shoulder Total Arthroplasty due to proximal humeral fracture. * Previous shoulder surgery including previous total shoulder arthroplasty or reverse total shoulder arthroplasty or hemiarthroplasty, or instability repairs * Active bacterial infection of the shoulder. * Any concomitant shoulder procedure. * Additional ipsilateral or contralateral upper limb pathology that requires active treatment (i.e. surgery or brace). * Inflammatory arthropathy. * Diagnosed with Rheumatoid arthritis * Diagnosed with gout. * Subject is on chronic anticoagulation due to a bleeding disorder or has taken anticoagulants within 10 days prior to surgery. * Peripheral vascular disease or other vascular disorders that would impair healing. * Peripheral neuropathy or other neurological disorders that may impair the patient to ambulate. * Patient is on workers compensation. * Any condition requiring chemotherapy. * Active tobacco user or former tobacco user who is not free of using tobacco for 8 weeks. * Uncontrolled Diabetes Mellitus with an HbA1C \> 7.5%. * Current drug or alcohol abuse. * Major medical illness (life expectancy less then 2 years or unacceptably high operative risk) * Suspicion of cervical radiculopathy or myelopathy. * Deltoid insufficiency on physical examination. Intra-operative: • Iatrogenic glenoid fracture Post-operative: * Neurological injury of the upper extremity. * Complications from Primary Reverse Shoulder Total Arthroplasty (i.e. post-operative infection, bleeding, hardware failure).
Where it's running
-
TRIA Orthopaedic Center
Bloomington, Minnesota, United States Recruiting
Study contacts
- Study coordinator: Megan Reams
- Email: megan.reams@tria.com
- Phone: 952-806-5329
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Steroid injections into myofascial trigger points versus joint injections for shoulder osteoarthritis
This study will test whether steroid injections into muscle trigger points work as well as steroid injections into the shoulder joint for adults with shoulder osteoarthritis and ongoing shoulder pain.
-
Using a wearable device to manage work-related shoulder pain
This study is testing a wearable device that helps workers with shoulder pain by giving them feedback on their movements to see if it can make their pain and work limitations better.
-
Personalized mobile health app to aid recovery after reverse shoulder arthroplasty
A personalized mobile app is tested to see if tailored information and rehab guidance help people recover better after reverse shoulder arthroplasty compared with standard care.
-
Using CBD to manage pain after shoulder surgery
This study is testing if a CBD medication can help people manage pain better after shoulder surgery compared to a placebo.
-
Evaluating the AETOS Shoulder System for shoulder replacement surgeries
This study is testing the AETOS Shoulder System to see if it is safe and effective for people with shoulder arthritis who need shoulder replacement surgery.
-
Comparing two methods of shoulder joint replacement for stability
This study is testing whether a new metal-based shoulder replacement technique is just as stable as the traditional bone-based method for people with shoulder arthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.